The Effect of Carer Training on Pressure Ulcers in Palliative Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Education group: aregivers in the experimental group will be given a detailed and planned training programme on pressure sores. The trainings will be held in a total of four sessions, with twenty minutes in each session, two weeks apart.
control group: In the first stage of the study, the participants in the experimental and control groups were asked to complete the 'Introductory Information Form' and '' Pressure sore knowledge test' will be completed. In the second stage of the research, no intervention will be made to the caregivers in the control group, and in the last stage of the research, 'Pressure sore knowledge test' will be filled in as post-test data for all participants.
Study summary
The aim of this article is to examine the effect of the training of carers caring for palliative care patients on the prevention and management of pressure ulcers. In this context, how the training affects the level of knowledge and practices of the carers will be evaluated. The findings obtained will contribute to improving the quality of patient care by providing strategic recommendations for the improvement of palliative care services.
Eligibility
Primary outcome measure(s)
- Pressure Wound Knowledge Test — 2 month
CBRT is a 3-point Likert type (true, false, don't know) questionnaire consisting of 17 questions prepared by the researchers in line with the literature. Five of the questions in the test were designed to be reverse scored and 12 were designed to be scored normally. The minimum score of the knowledge test is 0 and the maximum score is 17. The KR-20 value of this measurement tool was calculated as 0.80.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Firat University | Elâzığ | Elâzığ | Recruiting |
More Firat University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06565949 on ClinicalTrials.gov ↗ ← All trials in Turkey